Therapies

As a result of its solid and successful experience as partner with the Italian Health System, its significant expansion into international operations and a fundamental commitment to research and development, Kedrion’s line of plasma-derived products is broad and diverse.

With treatments for many rare and debilitating diseases and conditions from hemolytic disease in newborns to immune deficiencies to hemophilia, Kedrion offers a wide and expanding array of treatments and therapies.

Product Portfolio

RARE DISEASES

HEMATOLOGY / HEMOPHILIA  

RYPLAZIM***
Plasma-derived human Plasminogen

EMOCLOT / HUMACLOT / PLASMACLOT / EMOWIL / KLOTT* / KOĀTE***
Factor VIII Concentrate (with  Von Willebrand Factor)

NUWIQ**
Recombinant Factor VIII

WILFACTIN**
Von Willebrand Factor concentrate

AIMAFIX / KEDRIFIX / HUMAFACTOR-9 / IXED*
Factor IX concentrate

MONOFERRIC**
Iron replacement for intravenous infusion

EMOSINT
DDAVP Desmopressin

 

IMMUNOLOGY / NEUROLOGY

 Ig VENA / HUMAGLOBIN Liquid / KEDRIGAMMA / VENITAL*
Standard i.v. Immunoglobulin 5%

GAMMAKED***
Standard i.v. Immunoglobulin 10%

OPTIGLOBIN**
Standard i.v. Immunoglobulin 10%

NAXIGLO / KEYCUTE*
Standard s.c. Immunoglobulin

MOTHER AND CHILD HEALTH

RhoGAM / IMMUNORHO / KeYrho / MICRhoGAM
Anti-D i.m. Immunoglobulin

IMMUNOHBs 180 IU
Anti-Hepatitis B i.m. Immunoglobulin

CRITICAL CARE & TRANSPLANTATION

UMAN ALBUMIN / UMAN SERUM / HUMAN ALBUMIN / KEDRIALB / ALBITAL* / KEDBUMIN*** / ALBUKED*** / ALBUMINA LFB**
Human Albumin solution

KEDRAB***
Human Rabies Immunoglobulin

VENBIG / KEYVENB / VEBIKED
Anti-Hepatitis B i.v. Immunoglobulin

IMMUNOHBs / UMAN BIG / KEDHBs*
Anti-Hepatitis B i.m. Immunoglobulin

TETANUS GAMMA / TETIG
Anti-Tetanus i.m. Immunoglobulin

MONOFERRIC**
Iron replacement for intravenous infusion

UMAN COMPLEX / KEDCOM* / PRONATIV**
Prothrombin Complex concentrate

AT III KEDRION / ATKED*
Antithrombin concentrate

KOLFIB / SILKETAL*
Fibrin sealant

K FLEBO
Potassium aspartate

TRANSFUSION MEDICINE

CERUS INTERCEPT**
Plasma and platelets pathogen inactivation system

PLASMASAFE / PLASMAGRADE*
Pharmaceutical grade plasma

*Products for the Italian Self-Sufficiency Program
**Products in license
***Products only available for the US market

As of March 2022.

Orphan Drugs

Kedrion Human Plasminogen: a sterile human plasma derived plasminogen preparation in the pharmaceutical form of an eye drop solution for the treatment of Ligneous Conjunctivitis (currently under development product).
At the moment the product obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). The clinical trial is still ongoing for the Marketing Authorization approval in the USA and in Europe (EU).